Interv Akut Kardiol. 2021;20(2):78-80 | DOI: 10.36290/kar.2021.024

Cardiovascular complications and covid-19 infection

Petr Pařízek
1. interní kardioangiologická klinika, Fakultní nemocnice v Hradci Králové a Univerzita Karlova v Praze, Lékařská fakulta v Hradci Králové

Although the covid-19 disease predominantly affects the respiratory system, its negative effect on the cardiovascular system is also well known. The aim of this article is to present the causes and pathophysiological mechanisms of cardiovascular abnormalities during and after a covid-19 infection.

Keywords: cardiac injury, myocarditis, cardiomyopathy, arrhythmias, covid-19.

Published: July 9, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pařízek P. Cardiovascular complications and covid-19 infection. Interv Akut Kardiol. 2021;20(2):78-80. doi: 10.36290/kar.2021.024.
Zobrazit celý článek

Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Zheng YY, Ma YT, Zhang JY, Xie X. Covid-19 and the cardiovascular system. Nat Rev Cardiol 2020; 17: 259-260. Go to original source... Go to PubMed...
    2. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med 2020; 382(21): 2012-2022. Go to original source... Go to PubMed...
    3. Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with covid-19 in Wuhan, China. JAMA Cardiol 2020; 5(7): 802-810. Go to original source... Go to PubMed...
    4. Siripanthong B, Nazarian S, Muser D, et al. Recognizing covid-19-related myocarditis: the possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm 2020; 17(9): 1463-1471. Go to original source... Go to PubMed...
    5. Akhmerov A, Marbán E. Covid-19 and the heart. Circ Res 2020; 126(10): 1443-1455. Go to original source... Go to PubMed...
    6. Liu PP, Blet A, Smyth D, Li H. The science underlying covid-19: implications for the cardiovascular system. Circulation 2020; 142(1): 68-78. Go to original source... Go to PubMed...
    7. Chen L, Li X, Chen M, et al. The ACE2 expression in human heart indicates new potencial mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res 2020; 116(6): 1097-1100. Go to original source... Go to PubMed...
    8. Mitrani RD, Dabas N, Goldberger JJ. Covid-19 cardiac injury: implications for long-term surveillance and outcomes in survivors. Heart Rhythm 2020; 17(11): 1984-1990. Go to original source... Go to PubMed...
    9. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395(10229): 1054-1062. Go to original source... Go to PubMed...
    10. Guo T, Fan Y, Chen M, et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (covid-19). JAMA Cardiol 2020; 5(7): 811-818. Go to original source... Go to PubMed...
    11. Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (covid-19). JAMA Cardiol 2020; 5(11): 1265-1273. Go to original source... Go to PubMed...
    12. Huang L, Zhao P, Tang D, et al. Cardiac involvement in patients recovered from covid-2019 identified using magnetic resonance imaging. J Am Coll Cardiol Img 2020; 13: 2330-2339. Go to original source... Go to PubMed...
    13. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin. Eur Heart J 2021; 42(2): 206. Go to original source... Go to PubMed...
    14. Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (covid-19). JAMA Cardiol 2020; 5(7): 819-824. Go to original source... Go to PubMed...
    15. Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in Covid-19 cardiogenic shock. Eur J Heart Fail 2020; 22(5): 911-915. Go to original source... Go to PubMed...
    16. Wang T, Chen R, Liu C, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of Covid-19. Lancet Haematol 2020; 7(5): e362-e363. Go to original source... Go to PubMed...
    17. Klok FA, Kruip M, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with covid-19. Thromb Res 2020; 194: 145-147. Go to original source... Go to PubMed...
    18. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18(4): 844-847. Go to original source... Go to PubMed...
    19. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 323(11): 1061-1069. Go to original source... Go to PubMed...
    20. Gopinathannair R, Merchant FM, Lakkireddy DR, et al. Covid-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol 2020; 59(2): 329-336. Go to original source... Go to PubMed...
    21. Manolis AS, Manolis AA, Manolis TA, et al. Covid-19 infection and cardiac arrhythmias. Trends Cardiovasc Med 2020; 30(8): 451-460. Go to original source... Go to PubMed...
    22. Dherange P, Lang J, Qian P, et al. Arrhythmias and covid-19: a review. J Am Coll Cardiol Clin Electrophysiol 2020; 6(9): 1193-1204. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.